Literature DB >> 16083705

Mortality and hospital utilization for hepatocellular carcinoma in the United States.

W Ray Kim1, Gregory J Gores, Joanne T Benson, Terry M Therneau, L Joseph Melton.   

Abstract

BACKGROUND & AIMS: The incidence of hepatocellular carcinoma (HCC) has been increasing in the United States. Although resource-intensive treatment modalities have been increasingly applied, these patients still have poor survival. We examined 2 nationally representative databases, the Multiple Cause of Death file and the Nationwide Inpatient Sample database, to examine trends in mortality and hospital service utilization related to HCC.
METHODS: In both databases, a priori criteria were used to identify cases of HCC. All other available diagnostic fields were examined to characterize coexistent liver disease. Age-, sex-, and race-specific mortality from HCC was calculated, and temporal changes in mortality rates were evaluated using the multivariable Poisson model. Hospital service utilization was estimated based on length of stay, total hospitalization charges, and principal procedures.
RESULTS: The age-, sex-, and race-specific mortality from HCC increased from 1.54 to 2.58 per 100,000 per year between 1980 and 1998. Male sex, African and Asian race, and increasing age were also associated with higher mortality. The estimated total charge for HCC hospitalizations nationwide increased from 241 million US dollars in 1988 to 509 million US dollars in 2000 after inflation adjustment. Commonly employed procedures in 2000 included angiography/embolization, resection, local ablative therapy, and liver transplantation.
CONCLUSIONS: In the recent past, mortality and hospital service utilization related to HCC increased substantially. Closer epidemiologic surveillance to understand causation of HCC at the population level and to help implement primary and secondary prevention is urgently warranted.

Entities:  

Mesh:

Year:  2005        PMID: 16083705     DOI: 10.1016/j.gastro.2005.05.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

1.  Metastatic pancreatic adenocarcinoma presenting as a large pelvic mass mimicking primary osteogenic sarcoma: a series of two patient cases.

Authors:  Nicholas P Webber; Sunil Sharma; Allie H Grossmann; Akram Shaaban; Kevin B Jones; Lester J Layfield; R Lor Randall
Journal:  J Clin Oncol       Date:  2010-08-16       Impact factor: 44.544

2.  Hepatocellular carcinoma patients highly and specifically expressing XAGE-1 exhibit prolonged survival.

Authors:  Lei Gong; Jirun Peng; Zhuqingqing Cui; Pengcheng Chen; Hui Han; Dafang Zhang; Xisheng Leng
Journal:  Oncol Lett       Date:  2010-09-22       Impact factor: 2.967

3.  Model to estimate survival in ambulatory patients with hepatocellular carcinoma.

Authors:  Ju Dong Yang; W Ray Kim; Kyung Woo Park; Roongruedee Chaiteerakij; Bohyun Kim; Schuyler O Sanderson; Joseph J Larson; Rachel A Pedersen; Terry M Therneau; Gregory J Gores; Lewis R Roberts; Joong-Won Park
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

4.  Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008.

Authors:  Ju Dong Yang; Bohyun Kim; Schuyler O Sanderson; Jennifer L St Sauver; Barbara P Yawn; Rachel A Pedersen; Joseph J Larson; Terry M Therneau; Lewis R Roberts; W Ray Kim
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

5.  Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006.

Authors:  Chuanhui Dong; Young-Hee Yoon; Chiung M Chen; Hsiao-Ye Yi
Journal:  J Stud Alcohol Drugs       Date:  2011-11       Impact factor: 2.582

Review 6.  The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Authors:  Stephen Caldwell; Sang H Park
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

7.  Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.

Authors:  Wen-Wei Zhu; Jia-Jian Guo; Lei Guo; Hu-Liang Jia; Ming Zhu; Ju-Bo Zhang; Christopher A Loffredo; Marshonna Forgues; Hua Huang; Xu-Jian Xing; Ning Ren; Qiong-Zhu Dong; Hai-Jun Zhou; Zheng-Gang Ren; Nai-Qing Zhao; Xin Wei Wang; Zhao-You Tang; Lun-Xiu Qin; Qing-Hai Ye
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

8.  The marmoset model of GB virus B infections: adaptation to host phenotypic variation.

Authors:  Trudie Weatherford; Deborah Chavez; Kathleen M Brasky; Robert E Lanford
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City.

Authors:  Rafael Guerrero-Preston; Abby Siegel; John Renz; David Vlahov; Alfred Neugut
Journal:  J Community Health       Date:  2009-12

10.  Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

Authors:  Rohit Loomba; Hwai-I Yang; Jun Su; David Brenner; Elizabeth Barrett-Connor; Uchenna Iloeje; Chien-Jen Chen
Journal:  Am J Epidemiol       Date:  2013-01-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.